Education
About Us
Working with TipRanks
Follow Us
John Pottage Insider Profile
4 Followers
John Pottage, SVP and Chief Medical Officer at Achillion Pharmaceuticals, holds 12.50K shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds 75.00K shares in Spero Therapeutics (Ticker: SPRO), holds ― shares in Pardes Biosciences (Ticker: PRDS). Most recently, John Pottage ― shares of Achillion Pharmaceuticals on ― for an estimated value of ―.
John Pottage Achillion Pharmaceuticals (~ACHN)SVP and Chief Medical Officer
Achillion Pharmaceuticals (~ACHN)
SVP and Chief Medical Officer
Not Ranked
John Pottage has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that John Pottage holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by John Pottage
John Pottage's Trading History
Achillion Pharmaceuticals
―
―
―
$84.50K
Spero Therapeutics
Jun 16, 2025
Director
Uninformative Buy
―
$180.75K
Pardes Biosciences
―
―
―
―
List of latest transactions for each holding click on a transaction to see John Pottage's performance on stock
You May Also Like
John Pottage insider profile FAQ
What is the percentage of profitable transactions made by John Pottage?
The percentage of profitable transactions made by John Pottage is ―.
What is the average return per transaction made by John Pottage?
The average return per transaction made by John Pottage is ―.
What stocks does John Pottage hold?
John Pottage holds: ~ACHN, SPRO, PRDS stocks.
What was John Pottage’s latest transaction?
John Pottage latest transaction was an Uninformative Buy of ―.
What was John Pottage's most profitable transaction?
John Pottage’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is John Pottage's role in Achillion Pharmaceuticals?
John Pottage's role in Achillion Pharmaceuticals is SVP and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.